SuperworthGLAUKOS EPS GKOS
Diluted earnings per share by quarter and over the last twelve months, from 2014.
- Last 12 months, to Jun 30, 2026
- −$3.25
- Latest quarter, Q2 FY26
- −$0.31
- Fiscal year 2025
- −$3.26
GLAUKOS' earnings per share was −$3.25 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.31.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$3.26 | n/a |
| FY2024 | −$2.81 | n/a |
| FY2023 | −$2.78 | n/a |
| FY2022 | −$2.09 | n/a |
| FY2021 | −$0.14 | n/a |
| FY2020 | −$2.73 | −1150% |
| FY2019 | $0.26 | n/a |
| FY2018 | −$0.38 | n/a |
| FY2017 | −$0.01 | −108% |
| FY2016 | $0.12 | n/a |
| FY2015 | −$11.50 | n/a |
| FY2014 | −$5.31 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.31 | n/a | −$3.25 | |
| Q1 FY26 | −$0.34 | n/a | −$3.28 | |
| Q4 FY25 | −$2.32 | n/a | −$3.26 | |
| Q3 FY25 | −$0.28 | n/a | −$1.54 | |
| Q2 FY25 | −$0.34 | n/a | −$1.65 | |
| Q1 FY25 | −$0.32 | n/a | −$2.31 | |
| Q4 FY24 | −$0.60 | n/a | −$2.81 | |
| Q3 FY24 | −$0.39 | n/a | −$2.96 | |
| Q2 FY24 | −$1.00 | n/a | −$3.20 | |
| Q1 FY24 | −$0.82 | n/a | −$2.88 | |
| Q4 FY23 | −$0.75 | n/a | −$2.78 | |
| Q3 FY23 | −$0.63 | n/a | −$2.69 |
Against its peers
Companies in Medical - Instruments & Supplies nearest GLAUKOS' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| GKOSGLAUKOS | −$3.25 | |
| PODDInsulet | $5.35 | +64% a year |
| GMEDGlobus Medical | $3.91 | +50% a year |
| ALGNAlign Technology | $5.75 | −3% a year |
| COOCooper Companies | $2.93 | +44% a year |
| PENPenumbra | $4.07 | +8% a year |
| SOLVSolventum | $8.18 | +277% a year |
| MSAMSA Safety | $8.04 | +15% a year |
| MMSIMerit Medical Systems | $2.42 | +23% a year |
| HAEHaemonetics | $2.04 | −38% a year |
| VNTVontier | $2.41 | −8% a year |
| Peer median | $3.99 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on GLAUKOS
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.